Ftse Mib
34.938,90
0,45%
DAX
20.340,57
0,65%
S&P 500
5.909,03
-1,11%
NASDAQ
19.489,68
-1,89%
Bitcoin
96.222,35
-0,70%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Recursion Pharmaceuticals Inc (RXRX) Recursion Pharmaceuticals Inc (RXRX) Notizie

Recursion Pharmaceuticals Inc

RXRX
7,54
-0,41 (-5,16%)
08 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/1/202515:15GLOBERecursion Announces Two Key Investigational Oncology Drugs..
07/1/202500:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202514:30GLOBERecursion to Present at 43rd Annual JP Morgan Healthcare..
26/12/202422:24EDGAR2Form 144 - Report of proposed sale of securities
20/12/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:05GLOBERecursion Pharmaceuticals Reports Grant of Inducement Awards..
19/12/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:06EDGAR2Form 8-K - Current report
17/12/202423:05EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
11/12/202422:48EDGAR2Form 144 - Report of proposed sale of securities
10/12/202422:56EDGAR2Form 144 - Report of proposed sale of securities
10/12/202400:00GLOBERecursion Reports Interim Phase 1 Clinical Data for REC-617..
06/12/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202416:29EDGAR2Form 144 - Report of proposed sale of securities
04/12/202416:32EDGAR2Form 144 - Report of proposed sale of securities
03/12/202422:40EDGAR2Form 8-K - Current report
03/12/202414:30GLOBERecursion announces first patient dosed in Phase 1/2..
03/12/202401:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/11/202422:09EDGAR2Form 8-K/A - Current report: [Amend]
26/11/202422:48EDGAR2Form 8-K/A - Current report: [Amend]
23/11/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202400:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202422:24EDGAR2Form 144 - Report of proposed sale of securities
20/11/202413:14EDGAR2Form 8-K - Current report
20/11/202413:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/11/202413:00GLOBERecursion and Exscientia, two leaders in the AI drug..
20/11/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202419:06EDGAR2Form 144 - Report of proposed sale of securities
13/11/202422:42EDGAR2Form 8-K - Current report
13/11/202422:34EDGAR2Form 144 - Report of proposed sale of securities
13/11/202416:11EDGAR2Form 144 - Report of proposed sale of securities
13/11/202415:22EDGAR2Form 8-K - Current report
13/11/202415:08GLOBERecursion and Exscientia Shareholders Approve the Proposed..
12/11/202422:54GLOBERecursion Announces the Release of OpenPhenom-S/16 in Google..
12/11/202422:40EDGAR2Form 144 - Report of proposed sale of securities
12/11/202420:48EDGAR2Form 144 - Report of proposed sale of securities
06/11/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:17EDGAR2Form 8-K - Current report
06/11/202422:15GLOBERecursion Provides Business Updates and Reports Third..
06/11/202412:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/11/202412:05EDGAR2Form 8-K - Current report
04/11/202422:16EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
Apertura: 8,05 Min: 7,42 Max: 8,44
Chiusura: 7,95

La tua Cronologia

NASDAQ
RXRX
Recursion Pharmaceuticals
LSE
VLG
Venture Life
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network